Synergetics USA, Inc.
3845 Corporate Centre Drive
O'Fallon,
MO 63368
United States - Map
Phone: 636-939-5100
Fax: 636-939-6885
Web Site: http://www.synergeticsusa.com
| Synergetics USA, Inc., a medical device company, engages in the design, manufacture, and marketing of microsurgical instruments and consumables primarily for ophthalmology and neurosurgery markets in the United States and internationally. The companys product lines focus upon precision engineered, microsurgical, hand-held instruments, and the microscopic delivery of laser energy, ultrasound, electro surgery, aspiration, and illumination and irrigation that are delivered in multiple combinations. It also develops various microsurgical instruments, including scissors, fiberoptics, cannulas, forceps, and other reusable and disposable surgical instruments for ophthalmic and vitreoretinal surgical markets. Synergetics USAs neurosurgical product line includes Omni ultrasonic aspirator used for tumor removal; electrosurgical generators; bipolar electrosurgical systems; and other neurosurgical products, including energy source devices, and disposable and reusable instruments. In addition, the company offers a lesion generator, which is used for minimally invasive pain treatment, as well as manufactures directional laser probes. It sells its products to hospitals, clinics, and surgeons through direct sales employees, distributors, and independent sales representatives. The company was founded in 1991 and is headquartered in OFallon, Missouri. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. David M. Hable , 54
Chief Exec. Officer, Pres |
$
170.00K | N/A | Ms. Pamela G. Boone , 46
Chief Financial Officer, Exec. VP, Sec. and Treasurer |
N/A
| N/A | Mr. Kurt W. Gampp Jr., 49
Chief Operating Officer, Exec. VP |
$
368.00K | N/A | Mr. Jerry L. Malis , 76
Chief Scientific Officer, Exec. VP |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.63% Nasdaq 
0.03%
Profile
